These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30291756)

  • 1. Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients.
    Kojima S; Yanagisawa R; Tanaka M; Nakazawa Y; Shimodaira S
    Transfusion; 2018 Dec; 58(12):2952-2958. PubMed ID: 30291756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions.
    Kobayashi J; Yanagisawa R; Ono T; Tatsuzawa Y; Tokutake Y; Kubota N; Hidaka E; Sakashita K; Kojima S; Shimodaira S; Nakamura T
    Vox Sang; 2018 Feb; 113(2):128-135. PubMed ID: 29067694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.
    Yanagisawa R; Shimodaira S; Kojima S; Nakasone N; Ishikawa S; Momose K; Honda T; Yoshikawa K; Saito S; Tanaka M; Nakazawa Y; Sakashita K; Shiohara M; Akino M; Hirayama J; Azuma H; Koike K
    Transfusion; 2013 Sep; 53(9):2053-60. PubMed ID: 23252617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.
    Yamanaka M; Yanagisawa R; Kojima S; Nakazawa H; Shimodaira S
    Transfusion; 2019 Nov; 59(11):3405-3412. PubMed ID: 31532542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion outcome for volume- and plasma-reduced platelet concentrates for pediatric patients.
    Tanaka M; Yanagisawa R; Yamanaka M; Konno S; Takemura K; Kojima S; Okura E; Morita D; Saito S; Komori K; Matsuzawa H; Sakashita K; Tozuka M; Nakazawa Y
    Transfus Apher Sci; 2020 Aug; 59(4):102776. PubMed ID: 32561112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
    de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
    Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
    Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
    Infanti L; Holbro A; Passweg J; Bolliger D; Tsakiris DA; Merki R; Plattner A; Tappe D; Irsch J; Lin JS; Corash L; Benjamin RJ; Buser A
    Transfusion; 2019 Nov; 59(11):3350-3361. PubMed ID: 31574181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).
    Tobian AA; Fuller AK; Uglik K; Tisch DJ; Borge PD; Benjamin RJ; Ness PM; King KE
    Transfusion; 2014 Jun; 54(6):1523-9; quiz 1522. PubMed ID: 24251374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Transfusion; 2015 Nov; 55(11):2576-81. PubMed ID: 26095126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
    Högman CF; Eriksson L; Wallvik J; Payrat JM
    Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing adverse reactions in pediatric transfusions using washed platelet concentrate.
    Yanagisawa R
    Pediatr Int; 2021 Apr; 63(4):391-403. PubMed ID: 33290634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components.
    Aloui C; Barlier C; Awounou D; Thiam S; Fagan J; Claverol S; Tavernier E; Mounier C; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
    J Proteomics; 2020 Apr; 218():103717. PubMed ID: 32088354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of platelet additive solution-E stored platelet concentrates.
    Spelmink SE; Jager ST; van de Watering L; van der Meer PF; van Gammeren AJ; Wiersum-Osselton JC; Klei TRL; Kerkhoffs JH;
    Transfusion; 2023 Dec; 63(12):2273-2280. PubMed ID: 37909172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.
    Dijkstra-Tiekstra MJ; van de Watering LM; Rondeel JM; Slomp J; de Wildt-Eggen J
    Transfus Med; 2014 Apr; 24(2):99-104. PubMed ID: 24506143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.